Ramm Pharma Corp (TSE:RAMM) has released an update.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
RAMM Pharma Corp., a leader in cannabinoid pharmacology, has cancelled its previously announced private placement after withdrawing its appeal against the Canadian Securities Exchange’s decision which required shareholder approval. The company, with international production and sales in pharmaceuticals and hemp-based products, will communicate future financing plans at a later date. This strategic shift comes despite RAMM’s robust product pipeline and established market presence in Latin America and Europe.
For further insights into TSE:RAMM stock, check out TipRanks’ Stock Analysis page.